Current status and perspectives of protease inhibitors and their combination with nanosized drug delivery systems for targeted cancer therapy

M Rudzińska, C Daglioglu, LV Savvateeva… - Drug design …, 2021 - Taylor & Francis
In cancer treatments, many natural and synthetic products have been examined; among
them, protease inhibitors are promising candidates for anti-cancer agents. Since …
被引用次数：41 相关文章

Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy

M Rudzińska, C Daglioglu… - Drug Design …, 2021 - search.proquest.com
In cancer treatments, many natural and synthetic products have been examined; among
them, protease inhibitors are promising candidates for anti-cancer agents. Since …

Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy.

M Rudzihska, C Daglioglu, LV Savvateeva… - Drug Design …, 2021 - go.gale.com
In cancer treatments, many natural and synthetic products have been examined; among
them, protease inhibitors are promising candidates for anti-cancer agents. Since …

Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy

M Rudzińska, C Daglioglu… - Drug design …, 2021 - pubmed.ncbi.nlm.nih.gov
In cancer treatments, many natural and synthetic products have been examined; among
them, protease inhibitors are promising candidates for anti-cancer agents. Since …

Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy

M Rudzińska, C Daglioglu, L Savvateeva… - Drug Design …, 2021 - hal.science
In cancer treatments, many natural and synthetic products have been examined; among
them, protease inhibitors are promising candidates for anti-cancer agents. Since …

Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy

M Rudzińska, C Daglioglu… - Drug Design …, 2021 - eprints.whiterose.ac.uk
In cancer treatments, many natural and synthetic products have been examined; among
them, protease inhibitors are promising candidates for anti-cancer agents. Since …

Current status and perspectives of protease inhibitors and their combination with nanosized drug delivery systems for targeted cancer therapy

M Rudzinska, C Dağlıoğlu, L Savvateeva… - Drug Design …, 2021 - gcris.iyte.edu.tr
In cancer treatments, many natural and synthetic products have been examined; among
them, protease inhibitors are promising candidates for anti-cancer agents. Since …

Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy.

M Rudzińska, C Daglioglu, LV Savvateeva… - Drug Design …, 2021 - europepmc.org
In cancer treatments, many natural and synthetic products have been examined; among
them, protease inhibitors are promising candidates for anti-cancer agents. Since …

[引用][C] Current status and perspectives of protease inhibitors and their combination with nanosized drug delivery systems for targeted cancer therapy

M Rudzińska, LV Savvateeva, AA Zamyatnin… - Drug Design …, 2021 - elibrary.ru
[HTML] nih.gov

[HTML][HTML] Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy

M Rudzińska, C Daglioglu, LV Savvateeva… - Drug Design …, 2021 - ncbi.nlm.nih.gov
In cancer treatments, many natural and synthetic products have been examined; among
them, protease inhibitors are promising candidates for anti-cancer agents. Since …